nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—SLC22A2—nephron—nephrolithiasis	0.0652	0.225	CbGeAlD
Diphenhydramine—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0456	0.106	CbGpPWpGaD
Diphenhydramine—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.0315	0.0729	CbGpPWpGaD
Diphenhydramine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0287	0.0665	CbGpPWpGaD
Diphenhydramine—CYP2C19—urine—nephrolithiasis	0.0285	0.0982	CbGeAlD
Diphenhydramine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0267	0.0619	CbGpPWpGaD
Diphenhydramine—CYP1A2—urine—nephrolithiasis	0.0233	0.0802	CbGeAlD
Diphenhydramine—CYP2C9—urine—nephrolithiasis	0.0221	0.0761	CbGeAlD
Diphenhydramine—CYP2D6—urine—nephrolithiasis	0.0166	0.0571	CbGeAlD
Diphenhydramine—SLC22A2—nephron tubule—nephrolithiasis	0.0141	0.0486	CbGeAlD
Diphenhydramine—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0585	CcSEcCtD
Diphenhydramine—SLC22A2—renal system—nephrolithiasis	0.0128	0.0441	CbGeAlD
Diphenhydramine—SLC22A2—kidney—nephrolithiasis	0.0124	0.0427	CbGeAlD
Diphenhydramine—SLC22A2—cortex of kidney—nephrolithiasis	0.012	0.0416	CbGeAlD
Diphenhydramine—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0498	CcSEcCtD
Diphenhydramine—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0485	CcSEcCtD
Diphenhydramine—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0114	0.048	CcSEcCtD
Diphenhydramine—Tropicamide—CHRM3—nephrolithiasis	0.00922	0.219	CrCbGaD
Diphenhydramine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00913	0.0212	CbGpPWpGaD
Diphenhydramine—SLC22A1—renal system—nephrolithiasis	0.00904	0.0312	CbGeAlD
Diphenhydramine—Cyclopentolate—CHRM3—nephrolithiasis	0.00893	0.212	CrCbGaD
Diphenhydramine—SLC22A1—kidney—nephrolithiasis	0.00874	0.0301	CbGeAlD
Diphenhydramine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00849	0.0197	CbGpPWpGaD
Diphenhydramine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00836	0.0354	CcSEcCtD
Diphenhydramine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00826	0.0349	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00816	0.0345	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00781	0.033	CcSEcCtD
Diphenhydramine—Isopropamide—CHRM3—nephrolithiasis	0.00752	0.179	CrCbGaD
Diphenhydramine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00744	0.0315	CcSEcCtD
Diphenhydramine—HRH1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00707	0.0164	CbGpPWpGaD
Diphenhydramine—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00695	0.0161	CbGpPWpGaD
Diphenhydramine—SLC22A5—nephron tubule—nephrolithiasis	0.00691	0.0238	CbGeAlD
Diphenhydramine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00667	0.0282	CcSEcCtD
Diphenhydramine—SLC22A5—renal system—nephrolithiasis	0.00628	0.0217	CbGeAlD
Diphenhydramine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00611	0.0259	CcSEcCtD
Diphenhydramine—SLC22A5—kidney—nephrolithiasis	0.00607	0.0209	CbGeAlD
Diphenhydramine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00605	0.0256	CcSEcCtD
Diphenhydramine—CYP2B6—nephron tubule—nephrolithiasis	0.006	0.0207	CbGeAlD
Diphenhydramine—SLC22A5—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00599	0.0139	CbGpPWpGaD
Diphenhydramine—HRH1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00594	0.0138	CbGpPWpGaD
Diphenhydramine—SLC22A5—cortex of kidney—nephrolithiasis	0.00591	0.0204	CbGeAlD
Diphenhydramine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00587	0.0248	CcSEcCtD
Diphenhydramine—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00585	0.0135	CbGpPWpGaD
Diphenhydramine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00583	0.0247	CcSEcCtD
Diphenhydramine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00575	0.0133	CbGpPWpGaD
Diphenhydramine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00572	0.0242	CcSEcCtD
Diphenhydramine—CYP1A2—renal system—nephrolithiasis	0.00569	0.0196	CbGeAlD
Diphenhydramine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0056	0.0237	CcSEcCtD
Diphenhydramine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0055	0.0233	CcSEcCtD
Diphenhydramine—SLC22A5—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00548	0.0127	CbGpPWpGaD
Diphenhydramine—SLC22A5—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00548	0.0127	CbGpPWpGaD
Diphenhydramine—CYP2B6—renal system—nephrolithiasis	0.00545	0.0188	CbGeAlD
Diphenhydramine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00536	0.0124	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00534	0.0124	CbGpPWpGaD
Diphenhydramine—CYP2B6—kidney—nephrolithiasis	0.00527	0.0182	CbGeAlD
Diphenhydramine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00519	0.0219	CcSEcCtD
Diphenhydramine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00512	0.0217	CcSEcCtD
Diphenhydramine—CYP2C18—Biological oxidations—SLC26A1—nephrolithiasis	0.00509	0.0118	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00498	0.0115	CbGpPWpGaD
Diphenhydramine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00498	0.0211	CcSEcCtD
Diphenhydramine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00496	0.021	CcSEcCtD
Diphenhydramine—PTGS1—renal system—nephrolithiasis	0.00493	0.017	CbGeAlD
Diphenhydramine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00491	0.0208	CcSEcCtD
Diphenhydramine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00484	0.0205	CcSEcCtD
Diphenhydramine—PTGS1—kidney—nephrolithiasis	0.00477	0.0164	CbGeAlD
Diphenhydramine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00475	0.0201	CcSEcCtD
Diphenhydramine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0046	0.0194	CcSEcCtD
Diphenhydramine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00456	0.0193	CcSEcCtD
Diphenhydramine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00452	0.0191	CcSEcCtD
Diphenhydramine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00447	0.0189	CcSEcCtD
Diphenhydramine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00442	0.0187	CcSEcCtD
Diphenhydramine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00438	0.0185	CcSEcCtD
Diphenhydramine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00435	0.0184	CcSEcCtD
Diphenhydramine—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00426	0.00988	CbGpPWpGaD
Diphenhydramine—Brompheniramine—CHRM3—nephrolithiasis	0.00423	0.101	CrCbGaD
Diphenhydramine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00419	0.0177	CcSEcCtD
Diphenhydramine—SLC22A5—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00415	0.00961	CbGpPWpGaD
Diphenhydramine—SLC22A5—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00415	0.00961	CbGpPWpGaD
Diphenhydramine—CYP2D6—renal system—nephrolithiasis	0.00405	0.014	CbGeAlD
Diphenhydramine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00404	0.0171	CcSEcCtD
Diphenhydramine—CYP2D6—kidney—nephrolithiasis	0.00392	0.0135	CbGeAlD
Diphenhydramine—SLC22A5—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00386	0.00894	CbGpPWpGaD
Diphenhydramine—SLC22A5—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00386	0.00894	CbGpPWpGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00377	0.00873	CbGpPWpGaD
Diphenhydramine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00365	0.0154	CcSEcCtD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00351	0.00813	CbGpPWpGaD
Diphenhydramine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00348	0.0147	CcSEcCtD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00345	0.00798	CbGpPWpGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00345	0.00798	CbGpPWpGaD
Diphenhydramine—SLC22A5—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00344	0.00797	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00341	0.00791	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00341	0.00791	CbGpPWpGaD
Diphenhydramine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00336	0.0142	CcSEcCtD
Diphenhydramine—PTGS1—Biological oxidations—SLC26A1—nephrolithiasis	0.00328	0.0076	CbGpPWpGaD
Diphenhydramine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00323	0.0137	CcSEcCtD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00321	0.00744	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00321	0.00744	CbGpPWpGaD
Diphenhydramine—Rash—Hydrochlorothiazide—nephrolithiasis	0.0032	0.0136	CcSEcCtD
Diphenhydramine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0032	0.0135	CcSEcCtD
Diphenhydramine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00318	0.0135	CcSEcCtD
Diphenhydramine—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.00309	0.00716	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00304	0.00705	CbGpPWpGaD
Diphenhydramine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00302	0.0128	CcSEcCtD
Diphenhydramine—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00296	0.00686	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00278	0.00645	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00278	0.00645	CbGpPWpGaD
Diphenhydramine—Promethazine—CHRM3—nephrolithiasis	0.00276	0.0657	CrCbGaD
Diphenhydramine—Doxepin—CHRM3—nephrolithiasis	0.00274	0.065	CrCbGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00261	0.00605	CbGpPWpGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00261	0.00605	CbGpPWpGaD
Diphenhydramine—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00252	0.00583	CbGpPWpGaD
Diphenhydramine—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.0025	0.0058	CbGpPWpGaD
Diphenhydramine—HRH1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00244	0.00565	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00243	0.00564	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00243	0.00564	CbGpPWpGaD
Diphenhydramine—Promazine—CHRM3—nephrolithiasis	0.00243	0.0578	CrCbGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00243	0.00562	CbGpPWpGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00243	0.00562	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00226	0.00524	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00226	0.00524	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00218	0.00506	CbGpPWpGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00216	0.00501	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00215	0.00498	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00215	0.00498	CbGpPWpGaD
Diphenhydramine—Imipramine—CHRM3—nephrolithiasis	0.00213	0.0506	CrCbGaD
Diphenhydramine—Amitriptyline—CHRM3—nephrolithiasis	0.00212	0.0503	CrCbGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00211	0.00488	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00211	0.00488	CbGpPWpGaD
Diphenhydramine—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00208	0.00482	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00208	0.00482	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00202	0.00467	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.002	0.00464	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.002	0.00464	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00196	0.00454	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00196	0.00454	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00191	0.00443	CbGpPWpGaD
Diphenhydramine—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.00189	0.00438	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00178	0.00413	CbGpPWpGaD
Diphenhydramine—HRH1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00176	0.00409	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00175	0.00406	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00175	0.00406	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00175	0.00405	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00175	0.00405	CbGpPWpGaD
Diphenhydramine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00174	0.00403	CbGpPWpGaD
Diphenhydramine—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00172	0.00399	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00163	0.00378	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00163	0.00378	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00158	0.00366	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.00147	0.00341	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0014	0.00324	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00136	0.00316	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00134	0.00311	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00133	0.00307	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00133	0.00307	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00124	0.00287	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00124	0.00287	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00123	0.00286	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00123	0.00286	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00117	0.00271	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00115	0.00266	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00115	0.00266	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00115	0.00266	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GRHPR—nephrolithiasis	0.00115	0.00266	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0011	0.00255	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0011	0.00255	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00103	0.00239	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00102	0.00237	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00102	0.00237	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AGXT—nephrolithiasis	0.00102	0.00237	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00101	0.00235	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.000935	0.00217	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.00092	0.00213	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00089	0.00206	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000879	0.00204	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000876	0.00203	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—APRT—nephrolithiasis	0.00087	0.00202	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—SLC26A1—nephrolithiasis	0.00087	0.00202	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000819	0.0019	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.000814	0.00189	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000801	0.00186	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GRHPR—nephrolithiasis	0.000762	0.00177	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GRHPR—nephrolithiasis	0.00074	0.00171	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GRHPR—nephrolithiasis	0.000711	0.00165	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000695	0.00161	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000684	0.00159	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AGXT—nephrolithiasis	0.000679	0.00157	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AGXT—nephrolithiasis	0.00066	0.00153	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	0.00065	0.0015	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.000639	0.00148	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AGXT—nephrolithiasis	0.000633	0.00147	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	0.000632	0.00146	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	0.000621	0.00144	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AQP1—nephrolithiasis	0.00062	0.00144	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	0.000578	0.00134	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—APRT—nephrolithiasis	0.000578	0.00134	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GRHPR—nephrolithiasis	0.000565	0.00131	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—SLC26A1—nephrolithiasis	0.000561	0.0013	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—APRT—nephrolithiasis	0.000561	0.0013	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CHRM3—nephrolithiasis	0.000561	0.0013	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RGS14—nephrolithiasis	0.000552	0.00128	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	0.000543	0.00126	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	0.000538	0.00125	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—APRT—nephrolithiasis	0.000538	0.00125	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AGXT—nephrolithiasis	0.000503	0.00117	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000503	0.00116	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000495	0.00115	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	0.00046	0.00107	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000457	0.00106	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	0.000453	0.00105	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000449	0.00104	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	0.000428	0.000991	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APRT—nephrolithiasis	0.000428	0.000991	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000427	0.000989	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PTH—nephrolithiasis	0.000418	0.000968	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AQP1—nephrolithiasis	0.000412	0.000954	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	0.000411	0.000952	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AQP1—nephrolithiasis	0.0004	0.000926	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000392	0.000909	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000389	0.000901	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AQP1—nephrolithiasis	0.000384	0.000889	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.00038	0.000881	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DGKH—nephrolithiasis	0.000373	0.000864	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000373	0.000864	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CHRM3—nephrolithiasis	0.000372	0.000863	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	0.000367	0.000851	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000367	0.000851	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CHRM3—nephrolithiasis	0.000361	0.000837	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.00035	0.00081	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CHRM3—nephrolithiasis	0.000347	0.000804	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000347	0.000803	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000332	0.00077	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000323	0.000749	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000323	0.000749	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AQP1—nephrolithiasis	0.000305	0.000706	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000297	0.000689	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000297	0.000689	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000296	0.000687	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000295	0.000683	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000295	0.000683	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CHRM3—nephrolithiasis	0.000276	0.000639	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	0.00027	0.000625	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	0.000265	0.000615	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000252	0.000584	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000252	0.000584	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTH—nephrolithiasis	0.000247	0.000572	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTH—nephrolithiasis	0.000243	0.000562	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.00023	0.000534	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000212	0.000491	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.00021	0.000487	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CHRM3—nephrolithiasis	0.000208	0.000483	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000192	0.000444	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.00019	0.00044	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AQP1—nephrolithiasis	0.00018	0.000416	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CHRM3—nephrolithiasis	0.000162	0.000376	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SPP1—nephrolithiasis	0.000124	0.000287	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	0.000122	0.000282	CbGpPWpGaD
